title: [Ablation for atrial fibrillation in the elderly].
abstract: Atrial fibrillation is mainly an arrhythmia among the elderly. The current ESC guideline determines that there is no justification to deny atrial fibrillation ablation to any age group; however, the guideline does not provide specific scientific data. Thus, the goal of this article is to summarize the data on efficacy and safety of atrial fibrillation ablation among elderly people and give treatment recommendations: (1) The success of atrial fibrillation ablation is the same between elderly and younger patients. (2) In cohort studies there was a trend to higher stroke rates among elderly people. (3) Negative predictors for stroke are an age >80 years, heart failure, stroke in history, or/and CHA2DS2-VASc score ≥6.
authors.affiliation: Peter-Osypka-Herzzentrum München, Kliniken Dr. Müller München, Am Isarkanal 36, 81379, München, Deutschland. forschung@jilek.de.
authors.forename: Clemens
authors.initials: C
authors.lastname: Jilek
authors.affiliation: Peter-Osypka-Herzzentrum München, Kliniken Dr. Müller München, Am Isarkanal 36, 81379, München, Deutschland.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Lewalter
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000401:mortality* / Q000601:surgery*; D017115:Catheter Ablation / Q000401:mortality* / Q000706:statistics & numerical data*; D015984:Causality; D015897:Comorbidity; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D038622:Internationality; D008297:Male; D011183:Postoperative Complications / Q000401:mortality* / Q000517:prevention & control; D015995:Prevalence; D020521:Stroke / Q000401:mortality* / Q000517:prevention & control; D015996:Survival Rate; D016896:Treatment Outcome
keywords: Ablation; Atrial fibrillation; Efficacy; Quality of life; Stroke